CBD Oil For Schizophrenia
Emerging Research Into CBD Oil For The Treatment Of Schizophrenia
Marijuana is often discussed in a negative light due to the adverse effects it may have and since it is still considered illegal at the federal level and in most jurisdictions. However, it is important to consider the clinical applications of marijuana (and its derivatives) and its potential for therapeutic use. Specifically, cannabinoid (CBD) hemp oil can be used for conditions, such as whooping cough, asthma, pain, and sedation.
The latest research into the therapeutic benefits of marijuana has stunned the medical community. It has been shown that CBD oils have a significant positive impact on mental illnesses, such as schizophrenia and psychosis. CBD oil can be an instrumental treatment option for those who are dealing with these types of mental illnesses and had little to no response to current treatment options or the side effects are intolerable.
CBD Oil For Schizophrenia
Psychosis is a clinical term for a break with reality. The person experiencing psychosis may have delusions and/or hallucinations. This altered mental state may include delusions of persecution and/or delusions of grandeur. Hallucinations can include disturbances of sight, smell, and/or hearing. Psychosis is not a specific mental illness, but merely a symptom of a specific condition and a description of the person’s state of mind. Psychosis can be present in schizophrenia, bipolar disorder (both in manic and depressive phases), and schizoaffective disorder.
There is no debate that cannabis has advantages in the treatment of mental illnesses. However, the specific method by which it is helpful in the treatment of mental illnesses, such as schizophrenia, has been of recent interest. Pure delta-9-tetrahydrocannabinol (delta-9-THC), which contains reduced levels of THC, has specific threats to mentally ill clients. To negate these dangers, CBD is a better option due to the lower side effect profile.
A major concern with the use of CBD oil therapy for Schizophrenia is the possibility of the substance making people “high.” Fortunately, the use of CBD oil does not create any psychological or physiological effects that could be equated with feelings of euphoria, or “being high,” because it is low in the psychoactive substance, THC.
The antipsychotic effects of CBD are similar to a common antipsychotic medication, amisulpride. However, the adverse effects commonly seen in some antipsychotics, such as weight gain, movement disorders, and increased levels of prolactin, are not observed with the use of CBD.
It should be noted that the use of CBD oil for Schizophrenia, Biopolar, Anxiety and other mental illness’s are only in the early stages. So far, studies have indicated that there is an antipsychotic and anxiolytic effect created by CBD, which can be useful in the management of schizophrenia and related mental illnesses. It is also important to discuss the increased dopamine is associated with schizophrenia.
Anandamide, an endogenous cannabinoid, is found to neutralize the increased levels of dopamine. According to research studies, CBD oil increases the production of anandamide, this stops some of the activity of dopamine, which contributes to the symptoms associated with schizophrenia.
When considering the therapeutic use of CBD, its clinical applications for various mental and physical conditions include:
• CBD For Schizophrenia
- Medical use of cannabis. CBD: A new light for schizophrenia?
- A critical review of the antipsychotic effects of CBD: 30 years of a translational investigation
- Peripheral endocannabinoid system dysregulation in first-episode psychosis
- Cannabinoids and schizophrenia
- Antipsychotic-like effects of cannabidiol and rimonabant
- CBD monotherapy for treatment-resistant schizophrenia
- Cannabis with high CBD content is associated with fewer psychotic experiences
- Marijuana compound treats schizophrenia with few side effects: Clinical trial
- Clearing the smoke: what do we know about adolescent cannabis use and schizophrenia?
- Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments
• CBD For Bipolar disorder
- Cannabinoids in bipolar affective disorder: A review and discussion of their therapeutic potential
- Cannabidiol was ineffective for manic episode of bipolar affective disorder
• CBD For Anxiety
- CBD reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients
- Neural basis of anxiolytic effects of CBD in generalized social anxiety disorder
- Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation
- Effects of CBD on regional cerebral blood flow
- The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors
- The anxiolytic effect of CBD on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
- Plant-based medicines for anxiety disorders, part 2
- A systematic review of plant-derived natural compounds for anxiety disorders
- The Endocannabinoid System and Anxiety
• CBD For Seizures
- CBD exerts anti-convulsant effects in animal models of temporal lobe and partial seizures
- Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo
- Hypnotic and antiepileptic effects of CBD
- The cannabinoids as potential antiepileptics
- Cannabidiol–antiepileptic drug comparisons and interactions in experimentally induced seizures in rats
- CBD Post-Treatment Alleviates Rat Epileptic-Related Behaviors
- Pharmacology of cannabinoids in the treatment of epilepsy
- Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection
CBD Oil For Schizophrenia
Although the use of CBD oil for mental health conditions is new, there is substantial evidence that the treatment is promising for the management of schizophrenia and may be used as a standard option in the future.
CBD oil is not only an effective treatment option for mental illness, it is also well-tolerated, which can improve treatment compliance versus the use of some antipsychotic medications. There will need to be numerous clinical trials and other testing before CBD oil could be considered an acceptable treatment for schizophrenia. Fortunately, many studies are underway and it is only a matter of time before we have sufficient proof of the efficacy and safety of CBD oil for mental illness. We will update you accordingly once the evidence is available.